Critical Outcome Technologies Inc.

(COT:CA)

By |
Critical Outcome Technologies Inc.

Profile

Critical Outcome Technologies Inc is a biopharmaceutical company advancing the treatment of cancer through targeted therapeutics. Its compound COTI-2 has a novel p53-dependent mechanism of action with selective and potent anti-cancer activity.

Issuer Information

Exchange: CDX
NAICS: Pharmaceutical P
$ 0.46 $ 0.01 (1.11%)
Last Price 0.46 Change $ 0.01 Change % 1.11 Tick N/A
Bid 0.45 Bid Size 1,000.00 Ask 0.47 Ask Size 1,000.00
Open 0.47 High 0.47 Low 0.44 Prev Close 0.45
Last Trade Volume 127,400 52 Wk Hi 0.90 52 Wk Low 0.21
Market Cap 67.7 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 148,858,435.00 EPS (TTM) -0.06 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1 1 1 1.5
Low Target Price Estimate 1 1 1 1.5
Mean Target Price Estimate 1 1 1 1.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/20/16 05/20/16 05/20/16 08/17/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1